How does FDA device classification work?

By generic type rather than by rules. The FDA has assigned each recognised type of device to one of three classes and given it a three-letter product code. You identify the code that describes your device, and the class, the review panel and the premarket pathway follow from that entry. There is no cascade of rules to apply and no strictest-rule principle, because there is nothing to apply — the classification decision was made when the generic type was created.

What is an FDA product code?

A three-letter code identifying a generic type of device, such as FRN for an infusion pump. It is the key to the FDA's classification database: it carries the device class, the classification regulation in 21 CFR, the review panel, whether the type is exempt from premarket notification, and whether third-party review is available. Two devices with the same product code are regulated the same way.

Is Class II in the United States the same as Class IIa in Europe?

No. They are different scales reached by different methods. The FDA has three classes, the EU MDR has four, and the American classification is a property of the generic type rather than a conclusion about your particular device. A device can be Class II in the United States and Class I, IIa or IIb in Europe. Neither number can be derived from the other.

What is a predicate device, and do I need one?

A predicate is a legally marketed device to which you demonstrate substantial equivalence in a 510(k). Finding a product code does not establish that a suitable predicate exists — the code tells you the generic type is recognised, not that a specific device you can compare against is on the market. Identifying the predicate and building the comparison is separate work, and it is most of the submission.

What if no product code fits my device?

That is informative rather than a dead end. A device with no existing generic type cannot use the 510(k) route, because there is nothing to be substantially equivalent to. The De Novo pathway under section 513(f)(2) exists for exactly this: a request that the FDA classify a novel device of low or moderate risk into Class I or II, creating the generic type rather than joining one.

Does MDClassify determine my FDA class?

No, and deliberately not. For the United States it searches the FDA's published classification database and shows you the matching entries, with the class and pathway each one carries. You choose. Presenting the top match as the answer would dress a search result up as a determination, which is precisely the error the American system invites.

GUIDE

How the FDA classifies: product codes, not rules

Europe gives you twenty-two rules and expects you to apply them. The United States gives you a catalogue of roughly six thousand generic device types and expects you to find yours. Everything that follows — the class, the review pathway, whether you need a predicate — is read off the entry you land on, which makes finding the right one the whole job.

Written with Francesca Di Giuseppe, Senior QA/RA Specialist (LinkedIn)

Under review by Francesca Di Giuseppe, Senior QA/RA Specialist — this guide has not yet been through that review.

Two systems that answer different questions

European classification is deductive. You take the intended purpose, apply the rules of Annex VIII in turn, and the class is whatever the strictest applicable rule produces. Two competent people working from the same intended purpose should reach the same class, and where they do not, they can argue about which rule governs.

American classification is not like that. Under section 513 of the Federal Food, Drug, and Cosmetic Act, the FDA classified existing devices by generic type and has gone on adding types ever since. Each type sits in a classification regulation in 21 CFR Parts 862 to 892 and carries a class. Your device is not classified by reasoning; it is classified by being recognised as an instance of a type that was classified already.

Which changes what the work is

In Europe the difficulty is interpretive: does this device channel or store liquids within the meaning of Rule 2, does this software drive a therapeutic decision. In the United States the difficulty is one of identification: which of roughly six thousand generic types is mine, and is it really mine.

That is why this site classifies for the EU and searches for the US. It is not a feature gap. There is no American cascade to encode, and a tool that invented one would be describing a system that does not exist.

The three classes

CLASS	CONTROLS	USUAL PATHWAY TO MARKET
I	General controls	Most types are exempt from premarket notification. Exempt does not mean unregulated: registration, listing, labelling, and the Quality System Regulation still apply, and the exemption has limits written into the classification regulation itself.
II	General and special controls	510(k) premarket notification, demonstrating substantial equivalence to a legally marketed predicate. Some Class II types are also exempt; the classification regulation says which.
III	Premarket approval	PMA — an independent demonstration of safety and effectiveness, not a comparison. The most demanding route, and the one where clinical evidence is normally unavoidable.

NOTE —

Three classes against Europe's four, and the boundaries do not line up. Class II spans devices that Europe would place in IIa and in IIb; Class III is narrower than the European Class III in some areas and wider in others. There is no conversion table, and any table that claims to be one is inviting you to skip the work.

What a product code actually carries

A product code is three letters — FRN for an infusion pump, LKK for an electroencephalograph. It looks like an index number and behaves like a decision. Behind it sits an entry in the FDA's classification database holding, at minimum:

The device class, and therefore the controls that apply.
The classification regulation — a citation in 21 CFR whose text defines the generic type in words. This is the part worth reading: the definition is what you are claiming to match.
The review panel, meaning the medical speciality that will look at the submission.
The submission type — 510(k), PMA, De Novo, or exempt.
Flags for implants, for life-sustaining or life-supporting devices, and for eligibility for third-party review.

Some entries carry no regulation number

A minority of codes have no classification regulation behind them. These are types the FDA has recognised for administrative purposes without a codified classification, and the class shown against them is best read as proposed rather than settled. Our search marks these explicitly, because a class with no regulation to cite is not a class you can rely on in a submission.

Finding your code, and the trap in the naming

FDA device names are written noun-first with the qualifiers trailing: Pump, Infusion, not Infusion pump. Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days, not the phrase any clinician would use.

This matters more than it sounds. Search for the words in the order you would say them and the base type — the one you probably want — ranks below its own derivatives, because the derivatives happen to contain your phrase and the base type does not. It is the single most common way people end up on the wrong code, and it is the reason our search treats the inverted form as a first-class match rather than a coincidence.

Read the regulation text, not the name

A device name is a label; the classification regulation is a definition. Two codes with similar names can have definitions that differ on exactly the point that matters — duration of contact, whether the device is powered, which part of the body. Landing on a plausible name and stopping there is how a submission gets a refuse-to-accept letter months later.

A code is not a predicate

The two are routinely confused. Finding the right product code establishes that the FDA recognises your generic type and tells you which pathway applies. It does not establish that a suitable predicate device exists, and for a 510(k) you need one: a specific, legally marketed device whose intended use and technological characteristics you can show yours to be substantially equivalent to. That comparison is most of the submission, and no classification search can do it for you.

When nothing fits

If no generic type describes your device, the 510(k) route is closed by definition — there is nothing to be equivalent to. Novel devices of low or moderate risk are handled by the De Novo pathway, in which you ask the FDA to classify the device into Class I or II on the basis of risk, creating a new generic type rather than joining an existing one. A granted De Novo produces a new classification regulation and a new product code, which subsequent devices can then use as a predicate.

Where a device is genuinely high-risk and novel, the route is PMA rather than De Novo, and the evidentiary burden is of a different order.

If you are not sure, you can ask

Section 513(g) allows a formal request to the FDA for information on the class and requirements applicable to a device. It produces the agency's view rather than a guess, and it is a legitimate step for a product sitting on a boundary. It is not free and it is not instant, but neither is choosing wrongly.

The mistake worth naming

The recurring error is assuming the American class follows from the European one. Class IIa sounds like Class II, the numeral is the same, and there is a strong pull towards treating one as a translation of the other.

It is not. The European class is a conclusion about your device drawn from its intended purpose. The American class is a property of a generic type that the FDA classified, in some cases decades ago, on the evidence and risk understanding of the time. The two are answers to different questions, and the fact that they use overlapping numerals is an accident of drafting rather than a correspondence.

NOTE —

This is why MDClassify reports each market from its own instrument rather than mapping the European result outward. Where two markets share a class label, the tool says so and says that the labels agreeing does not mean the reasoning did.

Where to go next

Classification in the United States All markets compared UKCA marking in Great Britain Classify a device

NOTE —

The FDA publishes its classification database as a public file and replaces it weekly. MDClassify imports it and shows the date of the snapshot it searched, so you can tell how current the answer is — and check it against the FDA's own database before relying on it.